Fortress Biotech (NASDAQ:FBIO) Receives FDA Approval for UNLOXCYT™ for Treatment of cSCCOn December 13, 2024, Fortress Biotech, Inc. released an 8-K filing announcing a significant development for its majority-controlled subsidiary, Checkpoint Therap
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Fortress Biotech’s 8K filing here. About Fortress Biotech (Get Free Report) Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, […]
More Stories
Semler Scientific (NASDAQ:SMLR) Issues Press Release Detailing Bitcoin and ATM Activity
Semler Scientific, Inc. (NASDAQ: SMLR) recently filed an 8-K with the Securities and Exchange Commission detailing additional updates on its...
Analysts Set Golar LNG Limited (NASDAQ:GLNG) PT at $49.63
Shares of Golar LNG Limited (NASDAQ:GLNG – Get Free Report) have earned an average rating of “Moderate Buy” from the...
Energy Services of America Reports Strong Results for Fiscal Year 2024
Energy Services of America Corporation (NASDAQ: ESOA) recently disclosed its financial results for the fourth quarter and full fiscal year...
Taseko Mines Limited (NYSE:TGB) Receives Average Rating of “Buy” from Analysts
Taseko Mines Limited (NYSE:TGB – Get Free Report) has received an average recommendation of “Buy” from the four analysts that...
Tecnoglass Announces Increase in Quarterly DividendOn December 11, 2024, Tecnoglass Inc. (NASDAQ:TGLS) declared that its Board of Directors has given the green light to augment the quarterly dividend on its common shares to $0.15 per share, up from $
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...
Financial Comparison: Alpine Income Property Trust (NYSE:PINE) and Transcontinental Realty Investors (NYSE:TCI)
Transcontinental Realty Investors (NYSE:TCI – Get Free Report) and Alpine Income Property Trust (NYSE:PINE – Get Free Report) are both...